Eluminex Biosciences
Recent Finacing
Series B
Recent Raise
$40M
Eluminex Biosciences is an ophthalmic biotech developing retinal therapeutics and recombinant collagen cornea products, with R&D and GMP manufacturing in Suzhou and a clinical center in South San Francisco.
Highlights
Focus Areas
Health Diagnostics
Therapeutics
Recent Investors
Financials
$90M
Total Raised
2
Funding rounds
7
Investors